WASHINGTON, Dec 2 (Reuters) - The White House on Wednesday
pushed back against press reports that Federal Drug
Administration commissioner Steven Hahn had been called to the
White House to explain delays in approving a Pfizer coronavirus
vaccine, noting that such meetings are routine.
"What I will say about Dr. Hahn is, it is par for the course
for the Chief of Staff to meet with him as we're trying to save
American lives with the vaccine in record time," White House
Press Secretary Kayleigh McEnany said, regarding a meeting
between Hahn and White House Chief of Staff Mark Meadows that
Axios reported took place on Tuesday.
(Reporting by Andrea Shalal, Editing by Franklin Paul)
Astrazeneca (AZN)
